These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 53769)

  • 41. The effect of topical xylometazoline on the mucosal temperature of the nasal septum.
    Lindemann J; Leiacker R; Rettinger G; Keck T
    Am J Rhinol; 2002; 16(4):229-34. PubMed ID: 12222949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of effect on nasal discharge from a vasoconstrictor spray in common cold.
    Winther B; Brofeldt S; Borum P; Pedersen M; Mygind N
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():447-8. PubMed ID: 6194002
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparison of the chemical and biological methods for the evaluation of naphazoline and tetryzoline solutions in relation to their activity in vivo].
    Spinková V
    Cesk Farm; 1968 Dec; 17(10):483-5. PubMed ID: 4180770
    [No Abstract]   [Full Text] [Related]  

  • 44. A computed tomographic study of nasal mucosa: effects of vasoactive substances.
    Cole P; Haight JS; Cooper PW; Kassel EE
    J Otolaryngol; 1983 Feb; 12(1):58-60. PubMed ID: 6188856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On the effect of mucosa-shrinking nose drops].
    Osterwald L
    HNO; 1966 Feb; 14(2):39-41. PubMed ID: 4168347
    [No Abstract]   [Full Text] [Related]  

  • 46. Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo.
    Vermehren C; Johansen PB; Hansen HS
    Drug Metab Dispos; 1997 Sep; 25(9):1083-8. PubMed ID: 9311625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of absorption enhancers on nasal absorption of acyclovir.
    Chavanpatil MD; Vavia PR
    Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.
    Lebacq E; Gline JP; Joue P; Stockis A; Calderon P; Van Schoor O; Deroubaix X; Schwegler F
    Clin Trials Metaanal; 1994 Oct; 29(2-3):113-24. PubMed ID: 10151073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An experimental study on nasal absorption of gentamycin in dogs.
    Wang JQ; Bu GX
    Chin Med J (Engl); 1994 Mar; 107(3):219-21. PubMed ID: 8088184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacokinetic study on N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline), a new rhinologic drug].
    Neumann B; Brode E; Traut M
    Arzneimittelforschung; 1980; 30(10):1771-85. PubMed ID: 6159901
    [No Abstract]   [Full Text] [Related]  

  • 52. Absorption pharmacokinetics of clonidine nasal drops in children.
    Almenrader N; Larsson P; Passariello M; Haiberger R; Pietropaoli P; Lönnqvist PA; Eksborg S
    Paediatr Anaesth; 2009 Mar; 19(3):257-61. PubMed ID: 19143953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [EXPERIENCES WITH A NEW VASOCONSTRICTOR AND MUCOSAL DECONGESTIVE PREPARATION].
    HLADIK F
    Wien Med Wochenschr; 1963 Nov; 113():862-3. PubMed ID: 14114284
    [No Abstract]   [Full Text] [Related]  

  • 54. Function and structure of the nasal mucosa after 6 weeks' use of nose-drops.
    Petruson B; Hansson HA
    Acta Otolaryngol; 1982; 94(5-6):563-9. PubMed ID: 6184941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [TESTING OF NASAL DROPS: ACTION OF VARIOUS SOLUTIONS ON THE MUCOUS MEMBRANE OF THE GUINEA PIG AND MAN].
    ETTER JC; GRUMBACH PE; MIRIMANOFF A; PALEY A; SAVARY M
    Schweiz Med Wochenschr; 1964 Oct; 94():1531-4. PubMed ID: 14320745
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacological responsiveness of the nasal mucosa.
    Jackson RT
    Ann Otol Rhinol Laryngol; 1970 Jun; 79(3):461-7. PubMed ID: 4193454
    [No Abstract]   [Full Text] [Related]  

  • 57. AN OBJECTIVE INVESTIGATION OF THE DECONGESTIVE EFFECT OF XYLOMETAZOLINE.
    ASCHAN G; DRETTNER B
    Eye Ear Nose Throat Mon; 1964 Oct; 43():66-74. PubMed ID: 14217283
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of cold air and exercise on nasal patency.
    Cole P; Forsyth R; Haight JS
    Ann Otol Rhinol Laryngol; 1983; 92(2 Pt 1):196-8. PubMed ID: 6188407
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of nasal decongestants on the patency of the nose].
    Taniewski M; Walczak W
    Otolaryngol Pol; 1968; 22(5):695-8. PubMed ID: 4179689
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the galenical development of a nose spray from N-(2-imidazolin-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline) (author's transl)].
    Dechow HJ; Lämmerhirt K; Pich CH; Schikarski M
    Arzneimittelforschung; 1980; 30(10):1738-46. PubMed ID: 6159899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.